US Patent Issued to Amgen on July 8 for "Salt forms and solvates of Mcl-1 antagonists" (Indiana, California, Massachusetts Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,588, issued on July 8, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Salt forms and solvates of Mcl-1 antagonists" was invented by Henry Morrison (Thousand Oaks, Calif.), Jason S. Tedrow (Salem, Mass.), Stephan D. Parent (West Lafayette, Ind.), Courtney Johnson (West Lafayette, Ind.), Travis Houston (West Lafayette, Ind.) and Melanie Bevill (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are salt and solvate forms of. (1S,3'R,6'R,7'S,8'E,11'S,12'R)-6-chloro-7'-methoxy-11',12'-dimethyl-3,4-dihydro-2H,15'H-spiro[naphthalene-1,22'-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.03,6.019,24]pentacosa[8,16,18,24]te...